Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Certain Chinese herbs, especially Cacumen platycladi, can promote hair regrowth and reduce hair loss-related hormone levels in mice.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Genetic mutations can affect female sexual development, requiring personalized medical care.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Testosterone's muscle-building effects do not require its conversion to DHT.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

DHT, a testosterone byproduct, causes male pattern baldness.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Finasteride shows promise for female hair loss, but more research needed.